A model of 131I-huA33 pharmacodynamics in patients with colorectal carcinoma.

被引：0
|
作者：
Papenfuss, AT
Chong, G
Schleyer, PJ
Chappell, B
O'Keefe, GJ
Scott, AM
机构：
[1] Austin & Repatriat Med Ctr, Melbourne, Vic, Australia
[2] Ludwig Inst Canc Therapy, Melbourne, Vic, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
861
引用
收藏
页码：210P / 210P
页数：1
相关论文
共 50 条
  • [41] RECURRENCE RATE IN PATIENTS WITH SURGICALLY MANAGED STAGE I ENDOMETRIAL CARCINOMA.
    Kuljarusnont, S.
    Jaishuen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1411 - 1411
  • [42] Impact of patient's specification on clinical outcome for an I-131 ablation therapy with differentiated thyroid carcinoma.
    Nakayama, M.
    Okizaki, A.
    Sakaguchi, M.
    Uno, T.
    Sato, J.
    Ishitoya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S353 - S353
  • [43] TIME TO EVENT MODELING OF CODRITUZUMAB(GC33) ON OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA.
    Nakamura, M.
    Diack, C.
    Ohishi, N.
    Xu, C.
    Phipps, A.
    Rossin, C.
    Muehlig, A.
    Kawanishi, T.
    Ohtomo, T.
    Lee, R.
    Chen, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S54 - S54
  • [44] Ibandronate is effective in preventing skeletal events in patients with bone metastases secondary to colorectal carcinoma.
    Heras, P
    Karagiannis, S
    Kritikos, K
    Hatzopoulos, A
    Stavrinadis, I
    Mitsibounas, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 280S - 280S
  • [45] Hospital discharge of patients with thyroid carcinoma treated with 131I
    Venencia, CD
    Germanier, AG
    Bustos, SR
    Giovannini, AA
    Wyse, EP
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (01) : 61 - 65
  • [46] Fasting serum deoxycholic acid concentrations are increased in acromegalic patients with colorectal adenoma or carcinoma.
    Veysey, MJ
    Gathercole, DJ
    Thomas, LA
    Jenkins, P
    Fairclough, PD
    Besser, GM
    Murphy, GM
    Dowling, RH
    GASTROENTEROLOGY, 1997, 112 (04) : A674 - A674
  • [47] Dignostic value and clinic study of serum CA50 in patients with colorectal carcinoma.
    Yi, FZ
    FASEB JOURNAL, 1997, 11 (03): : 3109 - 3109
  • [48] Hemodialysis in patients requiring 131I treatment for thyroid carcinoma
    Fofi, Claudia
    Festuccia, Francescaromana
    Barberi, Simona
    Apponi, Francesca
    Chiacchiararelli, Laura
    Scopinaro, Francesco
    Punzo, Giorgio
    Mene, Paolo
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2013, 36 (06): : 439 - 443
  • [49] A phase I study of recombinant human arginase I (rhArgI) for patients with advanced hepatocellular carcinoma.
    Yau, C. C.
    Chan, P.
    Pang, R.
    Chan, W.
    Cheng, P. N.
    Poon, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma.
    Divgi, CR
    O'Donoghue, JA
    McGagh, DA
    Motzer, RJ
    Anwar, K
    Sheikh, A
    Gonzalez, RS
    Welt, S
    Old, LJ
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 217P - 217P
12345